| IQONE HEALTHCARE SWITZERLAND SA - Veblocema 120 mg, solution injectable en stylo prérempli |
| 67888 | | 01 | | Veblocema 120 mg | | solution injectable en stylo prérempli | | L04AB02 | | Infliximab | | 29.06.2021 | | |
|
| Composition |
| infliximabum 120 mg, acidum aceticum, natrii acetas trihydricus, sorbitolum 45 mg, polysorbatum 80, aqua ad iniectabile, q.s. ad solutionem pro 1 ml corresp. natrium 0.16 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Infliximab | 120 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Infliximab | 120 mg |
| | | | Inactive agents | Dose |
|---|
| Acetic Acid | | | Natrii Acetas Trihydricus | | | Polysorbatum 80 | | | Sorbitol | 45 mg/ml |
| |
|
|
